Polypharmacy Risk Screening

Polypharmacy Risk Screening is a systematic assessment method designed to identify individuals at increased risk of adverse health outcomes due to the concurrent use of multiple medications, distinguished by its focus on detecting potentially inappropriate prescribing, drug-drug interactions, and medication burden in clinical or research settings.

125

Publications

9.2K

Citations

708

Authors

362

Institutions

Publications per year

2017–2026

63

Authors

708

  1. UK
    Uwe K. Zettl

    University of Rostock, Germany

    3 publications · 78 citations

    3

    h-index

  2. MH
    Michael Hecker

    University of Rostock, Germany

    3 publications · 78 citations

    3

    h-index

  3. NF
    Niklas Frahm

    University of Rostock, Germany

    3 publications · 78 citations

    3

    h-index

  4. NT
    Nanako Tamiya

    University of Tsukuba, Japan

    3 publications · 59 citations

    3

    h-index

  5. GO
    Graziano Onder

    Università Cattolica del Sacro Cuore, Italy

    2 publications · 359 citations

    2

    h-index

1–5 of 708

Venues

  1. PubMed

    Repository · 5 publications · 544 citations

    5

    h-index

  2. Drugs & Aging

    5 publications · 687 citations

    5

    h-index

  3. PLoS ONE

    4 publications · 257 citations

    4

    h-index

  4. International Journal of Clinical Pharmacy

    3 publications · 92 citations

    3

    h-index

  5. 3

    h-index

1–5